Of interest and article archive

Here you will find selected articles from our archive.
For historical articles, please see here.

Go back

November 25, 2024

Thor Medical capital markets update: Enabling next-generation precision cancer treatments

November 22, 2024

Thor Medical signs agreement for supply of Pb-212 for pre-clinical use with globally leading pharmaceutical company

November 19, 2024

Thor Medical ships first product sample to potential customer from Herøya pilot facilities

November 1, 2024

Thor Medical invitation to capital markets update

October 29, 2024

Thor Medical and ARTBIO sign strategic long-term supply agreement for Thorium-228

September 26, 2024

Thor Medical completes Herøya pilot facilities and initiates commissioning

August 30, 2024

Thor Medical ASA reports first half 2024 results – Pilot facility progressing as planned and targeting ‘fast-track’ scale-up to commercial production

August 16, 2024

Invitation to presentation of Thor Medical ASA's first half results 2024

August 1, 2024

Jasper Kurth has assumed the position as CEO

June 26, 2024

Thor Medical receives DSA authorization for production of alpha-emitters at Herøya pilot plant

June 11, 2024

Thor Medical releases updated investor presentation

June 6, 2024

Thor Medical signs Memorandum of Understanding for feedstock supply and technology cooperation

Thor Medical logo

Contact
Thor Medical HQ

Karenslyst allé 9C
NO-0278 Oslo, Norway
Org.no: 994 297 422
MVA

+ 47 974 14 000

(08.00-16.00 CET)

post@thormedical.com

Design and development by

NXT Oslo Reklamebyrå

Sign up to news

Privacy statement

This service is operated by Investis Digital on behalf of Thor Medical. Investis Limited registered office is 24 Fashion Street, London, E1 6PX.

Full name
E-mail

Thank you!
Your submission has been received!

Oops! Something went wrong. Try again later.